# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA769455 | A | Cytotoxic dose at which 50% growth of normal cells is inhibited | Chlorocebus sabaeus | 47 | cell-based format | Scientific Literature | ||
2. | ALA768385 | F | Minimum drug concentration at which 99% of the polio virus is inhibited | Human enterovirus C | 39 | organism-based format | Scientific Literature | ||
3. | ALA768389 | F | Maximal non-toxic dose (MNTD) that shows antiviral activity. | Human enterovirus C | 61 | organism-based format | Scientific Literature | ||
4. | ALA766871 | F | The ratio of the poliovirus viral titer of the virus control (reduction factor) to the viral titer in the presence of the maximal non-toxic dose (RF MNTD) | Human enterovirus C | 48 | organism-based format | Scientific Literature | ||
5. | ALA766876 | F | Minimal dose which produces titer reduction at 10 ug/mL (mD RF10e3) | Human enterovirus C | 35 | organism-based format | Scientific Literature | ||
6. | ALA882153 | F | Cytotoxic dose at which 50% growth of normal cells is inhibited against rhino virus infection. | Human rhinovirus sp. | 28 | organism-based format | Scientific Literature | ||
7. | ALA799318 | F | Minimum drug concentration at which 99% of the rhino virus is inhibited. | Human rhinovirus sp. | 23 | organism-based format | Scientific Literature | ||
8. | ALA851081 | A | Therapeutic Index measured as the ratio of CyD50(polio) / ED99(polio) values | Human enterovirus C | 38 | organism-based format | Scientific Literature | ||
9. | ALA851082 | A | Therapeutic Index measured as the ratio of CyD50 (rhino) / ED99 (rhino) values. | 18 | assay format | Scientific Literature |